Connor, Clark & Lunn Investment Management (CC&L)’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $3.38M | Buy |
|
|||||
|
2021
Q2 | $3.29M | Sell |
|
|||||
|
2021
Q1 | $6.03M | Sell |
|
|||||
|
2020
Q4 | $6.61M | Buy |
|
|||||
|
2020
Q3 | $5.36M | Buy |
|
|||||
|
2020
Q2 | $6.92M | Sell |
|
|||||
|
2020
Q1 | $5.42M | Buy |
|
|||||
|
2019
Q4 | $4.09M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $397K | Sell |
|
|||||
|
2017
Q2 | $251K | Buy |
|
|||||
|
2017
Q1 | $210K | Buy |
|
|||||
|
2016
Q4 | $133K | Buy |
|
|||||
|
2016
Q3 | $152K | Buy |
|
|||||
|
2016
Q2 | $61K | Sell |
|
|||||
|
2016
Q1 | $151K | Sell |
|
|||||
|
2015
Q4 | $338K | Buy |
|
|||||
|
2015
Q3 | $188K | Buy |
|
|||||
|
2015
Q2 | $229K | Hold |
|
|||||
|
2015
Q1 | $394K | Buy |
|